Search Results - "Wilt, Jessie S."

Six-Minute-Walk Distance Predicts Waiting List Survival in Idiopathic Pulmonary Fibrosis by Lederer, David J, Arcasoy, Selim M, Wilt, Jessie S, D'Ovidio, Frank, Sonett, Joshua R, Kawut, Steven M

“…Functional studies may be useful to predict survival in idiopathic pulmonary fibrosis (IPF). Various cutoffs of 6-min-walk distance (6MWD) have been suggested…”
Get full text

Risk factors for venous thromboembolism after lung transplantation by Yegen, Hilary A, Lederer, David J, Barr, R Graham, Wilt, Jessie S, Fang, Yixin, Bagiella, Emilia, D'Ovidio, Frank, Okun, Jeffrey M, Sonett, Joshua R, Arcasoy, Selim M, Kawut, Steven M

“…The risk factors for venous thromboembolism (VTE) following lung transplantation are not well established. We aimed to estimate the incidence of VTE and to…”
Get more information

Platelet-derived growth factor is increased in pulmonary capillary hemangiomatosis by Assaad, Adel M, Kawut, Steven M, Arcasoy, Selim M, Rosenzweig, Erika B, Wilt, Jessie S, Sonett, Joshua R, Borczuk, Alain C

“…Pulmonary capillary hemangiomatosis (PCH) is a rare cause of pulmonary arterial hypertension with no effective medical therapy and a high risk of mortality…”
Get more information

The Modification of Diet in Renal Disease (MDRD) and the Prediction of Kidney Outcomes After Lung Transplantation by Al-Naamani, Nadine, MD, Maarouf, Omar H., MD, Wilt, Jessie S., MD, Bacchetta, Matthew, MD, D'Ovidio, Frank, MD, PhD, Sonett, Joshua R., MD, Arcasoy, Selim M., MD, Lederer, David J., MD, MS, Nickolas, Thomas L., MD, MS, Kawut, Steven M., MD, MS

“…Background Chronic kidney disease (CKD) is prevalent after lung transplantation. This study evaluated the ability of the 24-hour urine creatinine clearance…”
Get full text

Obesity and Underweight Are Associated with an Increased Risk of Death after Lung Transplantation by Lederer, David J, Wilt, Jessie S, D'Ovidio, Frank, Bacchetta, Matthew D, Shah, Lori, Ravichandran, Shankari, Lenoir, Jenny, Klein, Brenda, Sonett, Joshua R, Arcasoy, Selim M

“…Obesity is considered a relative contraindication to lung transplantation, based on studies that have not accounted for key confounders. Little is known about…”
Get full text

Osteoporosis in diffuse parenchymal lung disease by Caplan-Shaw, Caralee E, Arcasoy, Selim M, Shane, Elizabeth, Lederer, David J, Wilt, Jessie S, O'Shea, Mitchell K, Addesso, Vicki, Sonett, Joshua R, Kawut, Steven M

“…There are no studies focused on skeletal status in patients with diffuse parenchymal lung disease (DPLD). We hypothesized that patients with DPLD referred for…”
Get more information

Risk factors and outcomes of hypogammaglobulinemia after lung transplantation by KAWUT, Steven M, SHAH, Lori, WILT, Jessie S, DWYER, Edward, MAANI, Patricia A, DALY, Theresa M, O'SHEA, Mitchell K, SONETT, Joshua R, ARCASOY, Selim M

“…Hypogammaglobulinemia (HGG) frequently occurs after solid organ transplantation; however, the prevalence and implications of HGG after lung transplantation are…”
Get full text

Severe pulmonary hypertension due to chronic echinococcal pulmonary emboli treated with targeted pulmonary vascular therapy and hepatic resection by Bulman, William, Coyle, Christina M, Brentjens, Tricia E, Horn, Evelyn M, Dickstein, Marc L, Wilt, Jessie S, Emond, Jean, Kawut, Steven M

“…Hydatid disease (human echinococcosis) is a zoonotic infection caused by larval forms (metacestodes) of the genus Echinococcus. Although pulmonary hypertension…”
Get more information

Platelet activation in the postoperative period after lung transplantation by Sternberg, David I., MD, Shimbo, Daichi, MD, Kawut, Steven M., MD, MPH, Sarkar, Joydeep, BA, Hurlitz, Georg, MD, D'Ovidio, Frank, MD, Lederer, David J., MD, MPH, Wilt, Jessie S., MD, Arcasoy, Selim M., MD, Pinsky, David J., MD, D'Armiento, Jeanine M., MD, PhD, Sonett, Joshua R., MD

“…Objective During lung transplantation, cells in the pulmonary parenchyma are subjected to ischemia, hypothermic storage, and reperfusion injury. Platelets,…”
Get full text

Assessment of Kidney Function in Lung Transplant Candidates by Al-Naamani, Nadine, MD, Maarouf, Omar H., MD, Ahya, Vivek N., MD, Lederer, David J., MD, MS, Mendez, James D., MSN, RN, Wilt, Jessie S., MD, Doyle, Alden M., MD, Rybak, Debbie, BA, D'Ovidio, Frank, MD, PhD, Sonett, Joshua R., MD, Arcasoy, Selim M., MD, Nickolas, Thomas L., MD, MS, Kawut, Steven M., MD, MS

“…Background Glomerular filtration rate (GFR) is the best measure of kidney function; however, 24-hour creatinine clearance (CrCl) is the initial screening test…”
Get full text

Outcomes after Lung Retransplantation in the Modern Era by Kawut, Steven M, Lederer, David J, Keshavjee, Shaf, Wilt, Jessie S, Daly, Theresa, D'Ovidio, Frank, Sonett, Joshua R, Arcasoy, Selim M, Barr, Mark L

“…Characteristics of and survival estimates for recipients of lung retransplantation in the modern era are unknown. To compare lung retransplant patients in the…”
Get full text

Racial Differences in Waiting List Outcomes in Chronic Obstructive Pulmonary Disease by Lederer, David J, Benn, Emma K. T, Barr, R. Graham, Wilt, Jessie S, Reilly, Genevieve, Sonett, Joshua R, Arcasoy, Selim M, Kawut, Steven M

“…Blacks with chronic illness have poorer outcomes than whites in the United States. The health outcomes of minorities with chronic obstructive pulmonary disease…”
Get full text

Immunoglobulin G Levels before and after Lung Transplantation by Yip, Natalie H, Lederer, David J, Kawut, Steven M, Wilt, Jessie S, D'Ovidio, Frank, Wang, Yuanjia, Dwyer, Edward, Sonett, Joshua R, Arcasoy, Selim M

“…The determinants of immunoglobulin G (IgG) level and the risk of hypogammaglobulinemia (HGG) in patients with severe lung disease before and after lung…”
Get full text

Exercise testing determines survival in patients with diffuse parenchymal lung disease evaluated for lung transplantation by Kawut, Steven M., O’Shea, Mitchell K., Bartels, Matthew N., Wilt, Jessie S., Sonett, Joshua R., Arcasoy, Selim M.

“…Diffuse parenchymal lung disease is associated with a high risk of mortality despite early referral and listing for lung transplantation. We hypothesized that…”
Get full text

Outcomes of extended donor lung recipients after lung transplantation by KAWUT, Steven M, REYENTOVICH, Alexander, WILT, Jessie S, ANZECK, Roberto, LEDERER, David J, O'SHEA, Mitchell K, SONETT, Joshua R, ARCASOY, Selim M

“…Lung transplantation is currently limited by the number of suitable donor organs. Many lung-transplant programs use lungs that do not meet the formal criteria…”
Get full text

Successful bilateral lung transplantation for pulmonary fibrosis associated with the Hermansky-Pudlak syndrome by Lederer, David J, Kawut, Steven M, Sonett, Joshua R, Vakiani, Efsevia, Seward, Jr, Samuel L, White, James G, Wilt, Jessie S, Marboe, Charles C, Gahl, William A, Arcasoy, Selim M

“…Hermansky-Pudlak syndrome (HPS) is a genetic disorder characterized by oculocutaneous albinism, a bleeding diathesis, and in a subset of patients, pulmonary…”
Get more information

Surrogate Markers and Risk Factors for Chronic Lung Allograft Dysfunction by Bowdish, Michael E., Arcasoy, Selim M., Wilt, Jessie S., Conte, John V., Davis, Robert Duane, Garrity, Edward R., Hertz, Marshall L., Orens, Jonathan B., Rosengard, Bruce R., Barr, Mark L.

“…Obliterative bronchiolitis (OB) is the histologic correlate of chronic allograft dysfunction in pulmonary transplantation. The histologic diagnosis of OB is…”
Get full text

Cardiovascular improvements after lung transplantation in patients with cystic fibrosis by Layton, Aimee M, Rebmann, Rebecca A, De Meersman, Ronald E, Wilt, Jessie S, Bartels, Matthew N

“…Abstract only Due to a lack of published data, we investigated the effects of lung transplantation on cardiopulmonary parameters for patients with cystic…”
Get full text